Exclusive: CVC and Temasek to buy generics firm Alvogen, Alvogen's CEO says

http://wp.me/p55gzU-jQU

LONDON (Reuters) - European private equity fund CVC and Singaporean sovereign wealth fund Temasek [TEM.UL] are to buy a controlling stake in the pharmaceutical firm Alvogen, its chairman and chief executive said.

more: http://wp.me/p55gzU-jQU. #BusinessNews